Schneeweiss A - Search Results

1

Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.

Barinoff J, Schmidt M, Schneeweiss A, Schoenegg W, Thill M, Keitel S, Lattrich CR, Hinke A, Kutscheidt A, Jackisch C. Barinoff J, et al. Among authors: schneeweiss a. Eur J Cancer. 2017 Sep;83:116-124. doi: 10.1016/j.ejca.2017.06.002. Epub 2017 Jul 20. Eur J Cancer. 2017. PMID: 28735068

2

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer.

Huober J, Schneeweiss A, Hohaus S, Wittmann G, Meyer A, Martin S, Goldschmidt H, Bastert G, Haas R, Wallwiener D. Huober J, et al. Among authors: schneeweiss a. J Cancer Res Clin Oncol. 1998;124(12):690-4. doi: 10.1007/s004320050233. J Cancer Res Clin Oncol. 1998. PMID: 9879830 Clinical Trial.

3

Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.

Hohaus S, Funk L, Martin S, Schlenk RF, Abdallah A, Hahn U, Egerer G, Goldschmidt H, Schneeweiss A, Fersis N, Kaul S, Wallwiener D, Bastert G, Haas R. Hohaus S, et al. Among authors: schneeweiss a. Br J Cancer. 1999 Mar;79(9-10):1500-7. doi: 10.1038/sj.bjc.6690239. Br J Cancer. 1999. PMID: 10188897 Free PMC article.

4

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

Hohaus S, Martin S, Schneeweiss A, Voso MT, Schlenk RF, Wallwiener D, Bastert G, Haas R. Hohaus S, et al. Among authors: schneeweiss a. Cancer Chemother Pharmacol. 1999;44 Suppl:S13-7. doi: 10.1007/s002800051110. Cancer Chemother Pharmacol. 1999. PMID: 10602904 Clinical Trial.

5

Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: schneeweiss a. Stem Cells. 2002;20(1):32-40. doi: 10.1634/stemcells.20-1-32. Stem Cells. 2002. PMID: 11796920

6

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: schneeweiss a. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

7

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.

Schneeweiss A, Huober J, Sinn HP, von Fournier D, Rudlowski C, Beldermann F, Krauss K, Solomayer E, Hamerla R, Wallwiener D, Bastert G. Schneeweiss A, et al. Eur J Cancer. 2004 Nov;40(16):2432-8. doi: 10.1016/j.ejca.2004.08.004. Eur J Cancer. 2004. PMID: 15519516 Clinical Trial.

8

Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer.

Frickhofen N, Berdel WE, Opri F, Haas R, Schneeweiss A, Sandherr M, Kuhn W, Hossfeld DK, Thomssen C, Heimpel H, Kreienberg R, Hinke A, Möbus V; German Study Groups Arbeitsgemeinschaft Internistische Onkologie (AIO); Arbeitsgemeinschaft Gynäkologische Onkologie (AGO). Frickhofen N, et al. Among authors: schneeweiss a. Bone Marrow Transplant. 2006 Oct;38(7):493-9. doi: 10.1038/sj.bmt.1705472. Epub 2006 Aug 21. Bone Marrow Transplant. 2006. PMID: 16980997 Clinical Trial.

9

Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model.

Lux MP, Hartmann M, Jackisch C, Raab G, Schneeweiss A, Possinger K, Oyee J, Harbeck N. Lux MP, et al. Among authors: schneeweiss a. Breast Cancer Res Treat. 2009 Sep;117(2):305-17. doi: 10.1007/s10549-008-0294-9. Epub 2009 Jan 8. Breast Cancer Res Treat. 2009. PMID: 19130218 Free article.

10

Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

Untch M, Möbus V, Kuhn W, Muck BR, Thomssen C, Bauerfeind I, Harbeck N, Werner C, Lebeau A, Schneeweiss A, Kahlert S, von Koch F, Petry KU, Wallwiener D, Kreienberg R, Albert US, Lück HJ, Hinke A, Jänicke F, Konecny GE. Untch M, et al. Among authors: schneeweiss a. J Clin Oncol. 2009 Jun 20;27(18):2938-45. doi: 10.1200/JCO.2008.20.3133. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364964 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

663 results

Search Page